PharmTech Drug Digest 11.20
News|Articles|November 15, 2014

Pharmaceutical Technology

  • Pharmaceutical Technology-11-15-2014
  • Volume 2014 eBook
  • Issue 3

The Challenge of Finding the Unknown

Advanced analytical methods are speeding up the targeted evaluation of potential viral contaminants.

 

Advanced analytical methods are speeding up the targeted evaluation of potential viral contaminants.

 

Download Pharmaceutical Technology’s

2014 Analytical and Bioanalytical Testing eBook

.

Articles in this issue


Related to this article

white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.
Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.